Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Colorectal Neoplasms 58Carcinoma, Non-Small-Cell Lung 29Breast Neoplasms 18Rectal Neoplasms 14Ovarian Neoplasms 14Neoplasm Metastasis 10Carcinoma, Hepatocellular 10Glioblastoma 9Colonic Neoplasms 9Carcinoma, Renal Cell 8Uterine Cervical Neoplasms 7Fallopian Tube Neoplasms 7Brain Neoplasms 6Neoplasms 5Nasopharyngeal Carcinoma 5Lung Neoplasms 5Triple Negative Breast Neoplasms 4Recurrence 4Liver Neoplasms 4Inflammatory Breast Neoplasms 4Colorectal Cancer Metastatic 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Pleural Effusion, Malignant 3Meningeal Carcinomatosis 3Melanoma 3Kidney Neoplasms 3Glioma 3Non-squamous Non-small Cell Lung Cancer 2Liver Metastasis Colon Cancer 2

Interventions

Ipilimumab 3Triamcinolone Acetonide 2Ranibizumab 2Nivolumab 2Amplified Fragment Length Polymorphism Analysis 2treosulfan 1salicylhydroxamic acid 1aldesleukin 1Ultrasonography 1Tramadol 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Rose Bengal 1Radiosurgery 1Physical Examination 1Pharmacogenomic Testing 1Interviews as Topic 1Immunotherapy 1Ibuprofen 1Gemcitabine 1Eye Enucleation 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uveal Melanoma × Bevacizumab × Clear all
NCT01217398 2013-08-26

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡